.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Chubb
Covington
US Department of Justice
Boehringer Ingelheim
Cerilliant
Express Scripts
US Army
Fish and Richardson

Generated: November 20, 2017

DrugPatentWatch Database Preview

Wyeth Ayerst Company Profile

« Back to Dashboard

What is the competitive landscape for WYETH AYERST, and what generic and branded alternatives to WYETH AYERST drugs are available?

WYETH AYERST has eighty-two approved drugs.



Summary for Wyeth Ayerst

US Patents:0
Tradenames:64
Ingredients:56
NDAs:82
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst
UNIPEN
nafcillin sodium
INJECTABLE;INJECTION062717-002Dec 16, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
WYTENSIN
guanabenz acetate
TABLET;ORAL018587-002Sep 7, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
UNIPEN
nafcillin sodium
INJECTABLE;INJECTION062717-001Dec 16, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
PENBRITIN-S
ampicillin sodium
INJECTABLE;INJECTION050072-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
WYMOX
amoxicillin
FOR SUSPENSION;ORAL062131-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
EQUANIL
meprobamate
CAPSULE;ORAL012455-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
PEN-VEE K
penicillin v potassium
FOR SOLUTION;ORAL060007-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
OMNIPEN-N
ampicillin sodium
INJECTABLE;INJECTION060626-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
DIMENHYDRINATE
dimenhydrinate
INJECTABLE;INJECTION084316-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
PENBRITIN-S
ampicillin sodium
INJECTABLE;INJECTION050072-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Wyeth Ayerst

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst
WYTENSIN
guanabenz acetate
TABLET;ORAL018587-001Sep 7, 1982► Subscribe► Subscribe
Wyeth Ayerst
MAZANOR
mazindol
TABLET;ORAL017980-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Wyeth Ayerst
INDERAL
propranolol hydrochloride
SUSPENSION;ORAL019536-001Dec 12, 1986► Subscribe► Subscribe
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-002Jan 9, 1986► Subscribe► Subscribe
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-003Jan 9, 1986► Subscribe► Subscribe
Wyeth Ayerst
INDERIDE LA 80/50
hydrochlorothiazide; propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL019059-001Jul 3, 1985► Subscribe► Subscribe
Wyeth Ayerst
INDERIDE LA 160/50
hydrochlorothiazide; propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL019059-003Jul 3, 1985► Subscribe► Subscribe
Wyeth Ayerst
PMB 200
estrogens, conjugated; meprobamate
TABLET;ORAL010971-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Wyeth Ayerst
MAZANOR
mazindol
TABLET;ORAL017980-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Wyeth Ayerst
PMB 400
estrogens, conjugated; meprobamate
TABLET;ORAL010971-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cerilliant
Federal Trade Commission
Chubb
Daiichi Sankyo
Fuji
US Army
UBS
Covington
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot